أرسل هذا في رسالة قصيرة: Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

 __   _      ___      ____     __   __    ______  
| || | ||   / _ \\   |  _ \\   \ \\/ //  /_   _// 
| '--' ||  | / \ ||  | |_| ||   \ ` //   `-| |,-  
| .--. ||  | \_/ ||  | .  //     | ||      | ||   
|_|| |_||   \___//   |_|\_\\     |_||      |_||   
`-`  `-`    `---`    `-` --`     `-`'      `-`'